Active Ingredient Cytarabine
Active Ingredient Details
What is Cytarabine?
A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)
What is the usage for Cytarabine?
Cytarabine is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cancer cell growth.
How many products in the NDC database contain Cytarabine?
The NDC database has 20 products with the active ingredient Cytarabine. The following table lists all the products that have this active ingredient.
NDC Products with Cytarabine
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
12848-1003 | Proprietary Name: | Cytarabine | Powder | Asahi Kasei Finechem Co., Ltd. | ACTIVE | ||
25021-223 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Sagent Pharmaceuticals | ACTIVE | |
25021-229 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Sagent Pharmaceuticals | ACTIVE | |
55512-0026 | Proprietary Name: | Cytarabine | Powder | Archimica S.p.a. | ACTIVE | ||
58623-0026 | Proprietary Name: | Cytarabine | Powder | Zhejiang Hisun Pharmaceutical Co., Ltd. | ACTIVE | ||
61703-155 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Hospira, Inc. | ACTIVE | |
61703-303 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intravenous | Hospira, Inc. | ACTIVE | |
61703-304 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intravenous; Subcutaneous | Hospira, Inc. | ACTIVE | |
61703-305 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Hospira, Inc. | ACTIVE | |
61703-319 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Hospira, Inc. | ACTIVE | |
61703-319 | Proprietary Name: Cytarabine | Hospira Worldwide, Inc. | |||||
63323-120 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE | |
67430-075 | Proprietary Name: | Cytarabine | Powder | Pfanstiehl, Inc. | ACTIVE | ||
68083-337 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Gland Pharma Limited | ACTIVE | |
68083-343 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Gland Pharma Limited | ACTIVE | |
68727-745 | Proprietary Name: Vyxeos | (daunorubicin And Cytarabine) Liposome | Injection, Powder, Lyophilized, For Suspension | Intravenous | Jazz Pharmaceuticals, Inc. | ACTIVE | |
71288-108 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Meitheal Pharmaceuticals Inc. | ACTIVE | |
71288-109 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Meitheal Pharmaceuticals Inc. | ACTIVE | |
71288-168 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intravenous; Subcutaneous | Meitheal Pharmaceuticals Inc. | ACTIVE | |
71288-169 | Proprietary Name: Cytarabine | Cytarabine | Injection, Solution | Intravenous; Subcutaneous | Meitheal Pharmaceuticals Inc. | ACTIVE |